A dramatic decrease in the CAFs measured by immunostaining was observed in the FAP-mBBZ group, while CAFs were abundant in tumor lesions of the CLDN18.2-mBBZ CAR-T and UTD groups (Fig. 6a). The gene discussed is FAP; the disease is neoplasm.